IDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENIC PEPTIDES RECOGNIZED BY TUMOR-REACTIVE AND HLA-A2-OR A24-RESTRICTED CYTOTOXIC T-LYMPHOCYTES USEFUL FOR IMMUNOTHERAPY OF LUNG CANCER

Nishimura Yasuharu; Tomita Yusuke; Senju Satoru; Irie Atsushi; Mori Takeshi; Daigo Yataro; Tsunoda Takuya; Ito Takaaki; Nomori Hiroaki; Nakamura Yusuke; Kohrogi Hirotsugu

首页> 外文期刊>Tissue antigens. >IDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENIC PEPTIDES RECOGNIZED BY TUMOR-REACTIVE AND HLA-A2-OR A24-RESTRICTED CYTOTOXIC T-LYMPHOCYTES USEFUL FOR IMMUNOTHERAPY OF LUNG CANCER

【24h】

IDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENIC PEPTIDES RECOGNIZED BY TUMOR-REACTIVE AND HLA-A2-OR A24-RESTRICTED CYTOTOXIC T-LYMPHOCYTES USEFUL FOR IMMUNOTHERAPY OF LUNG CANCER

机译：识别可用于肺癌免疫治疗的肿瘤特异性和HLA-A2或A24限制性细胞毒T淋巴细胞识别的新型肿瘤相关抗原肽

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Tissue antigens.》 |2012年第6期|共1页
作者
Nishimura Yasuharu; Tomita Yusuke; Senju Satoru; Irie Atsushi; Mori Takeshi; Daigo Yataro; Tsunoda Takuya; Ito Takaaki; Nomori Hiroaki; Nakamura Yusuke; Kohrogi Hirotsugu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类人体形态学;
关键词

相似文献

外文文献
中文文献
专利

1. IDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENIC PEPTIDES RECOGNIZED BY TUMOR-REACTIVE AND HLA-A2-OR A24-RESTRICTED CYTOTOXIC T-LYMPHOCYTES USEFUL FOR IMMUNOTHERAPY OF LUNG CANCER [J] . Nishimura Yasuharu, Tomita Yusuke, Senju Satoru, Tissue antigens. . 2012,第6期

机译：识别可用于肺癌免疫治疗的肿瘤特异性和HLA-A2或A24限制性细胞毒T淋巴细胞识别的新型肿瘤相关抗原肽
2. Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K [J] . Ji Hee Lee, Myong-Suk Park, Jun-Eul Hwang, 中国免疫学杂志（英文版） . 2013,第003期

机译：基于HLA-A * 0201限制肿瘤相关抗原90K的细胞毒性T淋巴细胞表位的结肠癌基于树突细胞的免疫疗法
3. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen. [J] . Mami Chouaib F, Echchakir H, Dorothee G, Immunological reviews. . 2002,第0期

机译：人类肺癌中的抗肿瘤细胞毒性T淋巴细胞反应：与肿瘤相关的抗原的鉴定。
4. IN VIVO CYTOSOLIC DELIVERY OF EXOGENOUS ANTIGEN MEDIATED BY LISTERIOLYSIN O: ENHANCED CYTOTOXIC T-LYMPHOCYTE INDUCTION AND TUMOR PROTECTION [C] . M. Mandal, K.-D. Lee International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001

机译：脂溶素O介导的外源抗原的体内细胞液递送：增强的细胞毒性T淋巴细胞诱导和肿瘤保护
5. Carbohydrate derived nanoplatforms as tools for lectin isolation, and delivery of cytotoxic T-cell peptide epitopes for cytotoxic T-cell mediated tumor immunotherapy. [D] . Kavunja, Herbert Wanjala. 2015

机译：碳水化合物衍生的纳米平台作为凝集素分离的工具，以及细胞毒性T细胞肽表位的递送，用于细胞毒性T细胞介导的肿瘤免疫治疗。
6. Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K [O] . Ji Hee Lee, Myong-Suk Park, Jun-Eul Hwang, 2013

机译：基于HLA-A * 0201限制肿瘤相关抗原90K的细胞毒性T淋巴细胞表位的结肠癌基于树突细胞的免疫疗法
7. Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy [O] . Nobuoka, Daisuke, Yoshikawa, Toshiaki, Takahashi, Mari, 2013

机译：瘤内肽注射增强细胞毒性T淋巴细胞识别的肿瘤细胞抗原性：改善抗原特异性癌症免疫疗法的潜在选择
8. Identification of Widely Applicable Tumor-Associated Antigens for Breast Cancer Immunotherapy. [R] . Bai, J. 2006

机译：鉴定广泛适用的肿瘤相关抗原用于乳腺癌免疫治疗。

IDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENIC PEPTIDES RECOGNIZED BY TUMOR-REACTIVE AND HLA-A2-OR A24-RESTRICTED CYTOTOXIC T-LYMPHOCYTES USEFUL FOR IMMUNOTHERAPY OF LUNG CANCER

著录项

相似文献

相关主题

期刊订阅